CEF4, Influenza Virus NP (342-351) is a nucleoprotein-derived epitope utilized in studies of conserved viral antigenicity. Its structure supports assays examining peptide-MHC interactions and intracellular processing. Researchers analyze it to understand recognition of internal viral proteins. The peptide contributes to comparative epitope mapping research.
CAT No: C14004
1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
2. The spatiotemporal control of signalling and trafficking of the GLP-1R
4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.